Innovative Drug Discovery and Development
Formerly the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) which was formed in 2003, the Consortium for Innovative Drug Discovery and Development (GCC IDDD) is a research consortium focused on providing support for Houston/Galveston scientists in advancing their therapeutics discoveries through development to the clinic. IDDD support includes collaborative networking and joint funding opportunities, shared core resources, and educational programs.
Fannin Innovation Studio is Hiring!
Artificial Intelligence Shakes Up Drug Discovery
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
Thank you to everyone who helped make our Kickoff Mini-Symposium a success! For speaker and panel videos, Click Here.
Please save the date for this exciting conference and stay tuned for speaker updates. James Inglese, NIH/NCATS is confirmed.Find out more »
The newly reorganized Innovative Drug Discovery and Development (IDDD) Consortium (formerly Chemical Genomics) invites you to join us for the kick-off of our new program and focus on supporting […]Find out more »